Patent · US Active

Measurement of nicotinamde N-methyl transferase in diagnosis of lung cancer

US7785821B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignee

Roche Diagnostics Operations, Inc. · US

Inventors

Wolfgang Rollinger · Polling, DE
Marie-Luise Hagmann · Penzberg, DE
Johann Karl · Peißenberg, DE
Theresa Kott · Munich, DE
Markus Roessler · Germering, DE
Michael Tacke · Munich, DE

Key dates

Filing date	Jan 30, 2009
Grant date	Aug 31, 2010
Priority date	—
Expiry date	Jan 30, 2029

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/98
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to the assessment of lung cancer. It discloses the use of protein NNMT in the assessment of lung cancer. It also relates to a method for assessing lung cancer by measuring NNMT in vitro in a liquid sample derived from an individual. Measurement of NNMT can, e.g., be used in the early detection or in the follow-up of patients with lung cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.